These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 31319137)
41. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma. Tian J; Lu Z; Niu S; Zhang S; Ying P; Wang L; Zhang M; Cai Y; Dong T; Zhu Y; Zhong R; Wang Z; Chang J; Miao X Clin Transl Med; 2021 Jun; 11(6):e485. PubMed ID: 34185429 [TBL] [Abstract][Full Text] [Related]
42. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361 [TBL] [Abstract][Full Text] [Related]
43. miR-760 exerts an antioncogenic effect in esophageal squamous cell carcinoma by negatively driving fat metabolism via targeting c-Myc. Yang X; Zhang C; Tie H; Luo J; Wang Y; Wu Q J Cell Biochem; 2020 Apr; 121(4):2950-2961. PubMed ID: 31709636 [TBL] [Abstract][Full Text] [Related]
44. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760 [TBL] [Abstract][Full Text] [Related]
45. FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features. Islam F; Gopalan V; Law S; Tang JC; Lam AK Hum Pathol; 2019 May; 87():1-10. PubMed ID: 30794892 [TBL] [Abstract][Full Text] [Related]
46. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
47. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454 [TBL] [Abstract][Full Text] [Related]
48. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma. Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803 [TBL] [Abstract][Full Text] [Related]
49. SREBP2 is upregulated in esophageal squamous cell carcinoma and co‑operates with c‑Myc to regulate HMGCR expression. Zhong C; Fan L; Li Z; Yao F; Zhao H Mol Med Rep; 2019 Oct; 20(4):3003-3010. PubMed ID: 31432128 [TBL] [Abstract][Full Text] [Related]
50. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
51. MYC-binding lncRNA EPIC1 promotes AKT-mTORC1 signaling and rapamycin resistance in breast and ovarian cancer. Wang Y; Zhang M; Wang Z; Guo W; Yang D Mol Carcinog; 2020 Oct; 59(10):1188-1198. PubMed ID: 32810332 [TBL] [Abstract][Full Text] [Related]
52. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma. Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748 [TBL] [Abstract][Full Text] [Related]
53. CstF64-Induced Shortening of the Lin A; Ji P; Niu X; Zhao X; Chen Y; Liu W; Liu Y; Fan W; Sun Y; Miao C; Zhang S; Tan W; Lin D; Wagner EJ; Wu C Cancer Res; 2021 Nov; 81(22):5638-5651. PubMed ID: 34607841 [TBL] [Abstract][Full Text] [Related]
54. Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma. Roohinejad Z; Bahramian S; Shamsabadi FT; Sahebi R; Amini A; Sabour D; Shafiee M BMC Cancer; 2023 Jan; 23(1):34. PubMed ID: 36624401 [TBL] [Abstract][Full Text] [Related]
55. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc. Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674 [TBL] [Abstract][Full Text] [Related]
56. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma. Zhou Y; Wang L; Ban X; Zeng T; Zhu Y; Li M; Guan XY; Li Y Oncogene; 2018 Feb; 37(8):1086-1094. PubMed ID: 29106393 [TBL] [Abstract][Full Text] [Related]
58. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma]. Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413 [No Abstract] [Full Text] [Related]
59. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis. Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791 [TBL] [Abstract][Full Text] [Related]
60. The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma. Wang L; Li W; Li K; Guo Y; Liu D; Yao Z; Lin X; Li S; Jiang Z; Liu Q; Jiang Y; Zhang B; Chen L; Zhou F; Ren H; Lin D; Zhang D; Yeung SJ; Zhang H Cancer Med; 2018 Oct; 7(10):5205-5216. PubMed ID: 30270520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]